Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer

Fig. 6

a METTL3 expression in miR-186-5p overexpressed KY-SE150 and Eca-9706. b METTL3 expression in miR-186-5p knocked down KY-SE150 and Eca-9706. c Dual luciferase activity for METTL3 and miR-186-5p in KY-SE150. d Rescue experiments for the effect of METTL3 knock down and miR-186-5p knock down on METTL3 expression in KY-SE150. e, f Xenografts for SNHG3 knocked and NC group. g Expression of miR-186-5p in SNHG3 knocked down xenografts. 6H Expression of METTL3 in SNHG3 knocked down xenografts

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us